Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism NPAS2 inhibitors(neuronal PAS domain protein 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Wounds and Injuries | Preclinical | US | 01 Feb 2023 | |
Wounds and Injuries | Preclinical | - | 01 Feb 2023 |